What is CorMatrix Cardiovascular?
Founded in 2001 and headquartered in Roswell, Georgia, CorMatrix Cardiovascular operates at the intersection of biotechnology and medical device manufacturing. The company specializes in the development of the CorMatrix ECM platform, a sophisticated extracellular matrix designed to leverage the body's innate regenerative capabilities. By signaling the body to remodel and regrow damaged tissue, the technology provides a robust solution for complex clinical needs, including pericardial repair, vascular reconstruction, and the stabilization of implantable electronic devices. As a leader in the biomaterials sector, CorMatrix provides clinicians with tools that offer long-term structural integrity and resistance to infection, effectively bridging the gap between traditional surgical intervention and advanced biological healing.
How much funding has CorMatrix Cardiovascular raised?
CorMatrix Cardiovascular has raised a total of $24.6M across 1 funding round:
Private Equity
$24.6M
Private Equity (2011): $24.6M, investors not publicly disclosed
Key Investors in CorMatrix Cardiovascular
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for CorMatrix Cardiovascular?
Looking ahead, CorMatrix Cardiovascular is positioned to leverage its recent capital infusion to scale its commercial operations and expand the clinical applications of its ECM technology. The company's strategic roadmap focuses on deepening its penetration within the cardiovascular market while exploring new indications for its regenerative platform. By maintaining a focus on clinical efficacy and long-term patient outcomes, CorMatrix is well-equipped to navigate the complexities of the medical device landscape. Future growth will likely be driven by continued investment in research and development, ensuring that the firm remains at the forefront of tissue engineering and cardiovascular health innovation.
See full CorMatrix Cardiovascular company page
